Yükleniyor... / Loading...
This observational cohort study examines cognitive decline and its underlying mechanisms in patients with symptomatic intracranial artery stenosis. It enrolls patients aged 18-80 with severe stenosis who have had a transient ischemic attack or minor stroke and who receive medication (aspirin, clopidogrel, atorvastatin) or endovascular therapy. It is a study with no assigned phase and is currently recruiting participants.
The summary above is a plain-language rendering of the official record. The original English title is shown for reference.
Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.
Inclusion Criteria: * Age between 18 and 80 years * Severe stenosis (≥70%-99%) of atherosclerotic internal carotid artery (C6 segment, C7 segment) or middle cerebral artery (M1 segment) confirmed by digital subtraction angiography (DSA) or at least two of the following non-invasive examinations: magnetic resonance angiography (MRA), computed tomography angiography (CTA), or transcranial Doppler (TCD) * Transient ischemic attack (TIA) or minor stroke (National Institute of Health Stroke Scale \[NIHSS\] score ≤ 4 points) * Right-handed and able to cooperate in neuropsychological tests * At least 14 days post-onset of cerebral infarction or TIA * Signed informed consent Exclusion Criteria: * Other diseases that affect cognitive function, such as cerebral hemorrhage, •Parkinson's disease, neurosyphilis, dementia, tumors, etc. * Right upper limb hemiplegia, aphasia, visual field defects, or visual impairments * More than 50% stenosis of the extracranial internal carotid artery, the vertebral artery, or the basilar artery * Vasculitis, moyamoya disease, and cardiogenic stroke * Previous history of head and neck stent implantation, carotid endarterectomy, aneurysm embolization, or other intracranial surgeries